Field efficacy of HVT-H9 vaccination after natural infection of H9N2 avian influenza virus in broilers

Vet Microbiol. 2023 Jan:276:109624. doi: 10.1016/j.vetmic.2022.109624. Epub 2022 Dec 9.

Abstract

H9N2 subtype avian influenza virus (AIV) has been persistently circulating in China. It causes huge economic losses to the poultry industry and poses a great threat to public health. Previously, we constructed a turkey herpesvirus live vector vaccine candidate strain expressing an H9 gene, HVT-H9. Results showed that immunisation with HVT-H9 could provide good immunity in specific pathogen free (SPF) chickens. In this study, field-bred Arbour Acres plus (AA+) broilers were additionally immunised with HVT-H9 at one day of age. Then, broilers were naturally infected with H9N2 AIV. During the endemic period, death occurred in flocks without HVT-H9 immunisation and the mortality rate increased rapidly, forming a clear death wave. However, HVT-H9 vaccination prevented broiler mortality. Etiological tests and serological tests showed that broilers were positive for H9N2 AIV. Collectively, HVT-H9 immunisation provided good immunity for broilers in the field by inhibiting H9N2 virus infection and transmission.

Keywords: Broiler; Field efficacy; H9N2 AIV; HVT-H9; Natural infection; Vaccination.

MeSH terms

  • Animals
  • Chickens
  • Influenza A Virus, H9N2 Subtype* / genetics
  • Influenza in Birds*
  • Poultry
  • Poultry Diseases* / prevention & control
  • Vaccination / veterinary
  • Vaccines, Attenuated

Substances

  • Vaccines, Attenuated